HEXO Is on the Move

Investors in Hexo stock should take note of the cannabis firm’s management’s several moves during the past four weeks. 

| More on:

Investors in Hexo (TSX:HEXO)(NYSE:HEXO) stock should take note of the cannabis firm’s several strategic moves made recently. The Canada-based marijuana producer is busy executing its disclosed partnerships-led growth strategy, with several announcements coming out during the past four short weeks. The latest activity could impact valuation, even in the near term.

What has Hexo done recently?

In just four weeks, Hexo has made significant moves on the capital markets and operationally. Here are some of the notable actions management has taken since mid-April.

Capital markets activity

The company filed a $1.2 billion base-shelf prospectus on April 15. The filing signalled management’s serious intention to raise significant sums of capital for growth projects. The payment, on May 3, of $28.9 million to fully repay a syndicated credit facility with Canadian Imperial Bank of Commerce (CIBC) and Bank of Montreal (BMO) reduced leverage and interest risk.

However, the announcement of a $150 million at-the-market (ATM) on May 11 signalled management’s imminent moves on acquisitions and partnerships. The ATM allows the company to sell new shares directly to the public from time to time. The funds will be used to finance the ongoing U.S. expansion program, integrate a recently acquired Zenabis, improve production lines at the flagship Ontario facility, and boost working capital levels.

Operational developments

Hexo launched six new beverages in Canada on April 14. The company is moving to extend its market leadership in the beverages segment through the Truss Beverages partnership with Molson Coors. Consolidating leadership in a growing market segment could make the company a long-term winner. Though at its nascent stages, the cannabis-infused beverages segment could be a huge multi-billion-dollar market. And HEXO is already replicating early success in the United States.

We saw the company announce a brand partnership with REQ, an award-winning digital marketing agency in America on May 13. Hexo is already investing in strongly marketing its brands in the U.S. after recently launching operations in Colorado.

“REQ will evaluate HEXO’s brand presence on- and offline in the U.S. market and evolve the Powered by HEXO  brand in preparation for an exciting period of expansion and growth,” Management explained in a statement on Thursday.

The company made another significant move on Friday, May 14. Hexo announced the acquisition of a 50,000-square-foot manufacturing facility in northern Colorado for an undisclosed amount. The facility is already zoned for the production of “a full range of cannabinoids.” Word is that the U.S. facility is capable of processing non-beverage cannabinoid products, too.

The marijuana producer could just have put together what its undisclosed future U.S.-based partners desire before coming on board its “Powered by HEXO” platform.

Investor takeaway

Although shareholder dilution is a concern, it can be justified by quick execution for growth. The company’s management is moving fast on the operational side. And such quick execution matters; It could justify dilution pains for current shareholders if it produces quick results.

Hexo is putting together all the necessary pieces for its partnerships-led growth strategy into the United States. Management is still silent about who the company’s consumer packaged goods (CPG) partners are. But judging by the speed at which execution is going, something very significant could be in the pipeline.

Although there are still some significant marketing challenges for CBD as far as the U.S. Food and Drug Administration is concerned, partnerships with larger, well-established, and experienced non-beverage CPG firms help the company in navigating hurdles. The company won’t walk alone.

Simply put, here is a Canadian cannabis firm that could give its United States-based competitors a tough game. Hexo stock investors may justifiably expect the firm to be a serious contender in the CBD market tussles in America — more so given its prior success with partnerships in Canada. The company is making some good, purposeful, and well-timed moves before U.S. federal legalization intensifies local competition for capital on the open markets.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »